Skip to main content
. 2005 Jan 26;25(4):985–989. doi: 10.1523/JNEUROSCI.3099-04.2005

Figure 3.


Figure 3.

Enhancement of spike firing after direct activation of PKA by forskolin was not prevented by inhibition of aPKC. A, B, Examples showing enhancement of firing by forskolin that was inhibited by the PKA antagonist PKI but not by aPKC-PS or the scrambled peptide. C, Grouped data showing significant enhancement of spike firing by 3 or 5 μm forskolin after intracellular perfusion with aPKC-PS or the scrambled peptide.